Glycation Products as Markers and Predictors of the Progression of Diabetic Complications
The DOI matches its Crossref record.
Abstract
A bstract: The structure of a growing number of glycation and advanced glycation end products has been elucidated. Measuring these products can be used to assess cumulative glycemic and glycoxidative damage in diabetes and other chronic conditions. The predictive power of a given glycation product can be tested in large prospective studies that evaluate the risk of developing diabetic micro‐ and macrovascular disease over years following the quantitative determination of that marker. This article provides a comprehensive review of the field, comparing the merits of each marker, whether in skin, serum, or other tissue. Several conclusions are drawn, one of which identifies skin glycation products as powerful predictors of the risk of developing diabetic complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus
Nowotny, K., Jung, T., Höhn, A., Weber, D., & Grune, T. (2015) · Biomolecules · doi:10.3390/biom5010194 · Cited by 1,095
“Furthermore, accumulation of AGEs in diabetic tissue was shown to correlate with diabetic complications (reviewed in [42]).”
BackgroundChaudhuri, J., Bains, Y., Guha, S., Kahn, A., Hall, D., Bose, N., Gugliucci, A., & Kapahi, P. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.014 · Cited by 669
“Modified from: (Monnier et al., 2005).”
BackgroundVascular Aging: A Tale of EVA and ADAM in Cardiovascular Risk Assessment and Prevention
Nilsson, P. M., Boutouyrie, P., & Laurent, S. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.129114 · Cited by 380
Arterial stiffness in diabetes mellitus
Prenner, S. B., & Chirinos, J. A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.12.023 · Cited by 313
Molecular Basis of Arterial Stiffening: Role of Glycation – A Mini-Review
Sell, D. R., & Monnier, V. M. (2012) · Gerontology · doi:10.1159/000334668 · Cited by 282
Self-citationContinuous Glucose Monitoring Systems: A Review
Vashist, S. (2013) · Diagnostics · doi:10.3390/diagnostics3040385 · Cited by 261
Genuth, S., Sun, W., Cleary, P., Gao, X., Sell, D. R., Lachin, J., The DCCT/EDIC Research Group, & Monnier, V. M. (2015) · Diabetes · doi:10.2337/db14-0215 · Cited by 146
Self-citationAdvanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice
Rubin, M. R., Paschalis, E. P., Poundarik, A., Sroga, G. E., McMahon, D. J., Gamsjaeger, S., Klaushofer, K., & Vashishth, D. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154700 · Cited by 90
“Although the effects of diabetes on collagen non-enzymatic cross linking have been characterized [5, 11] more information is needed about how AGE accumulation affects bone material at both the macroscopic and microsopic levels.”
Plasma advanced glycation end products are decreased in obese children compared with lean controls
Šebeková, K., Somoza, V., Jarčušková, M., Heidland, A., & Podracká, L. (2009) · International Journal of Pediatric Obesity · doi:10.1080/17477160802248039 · Cited by 82
The dual face of endogenous α-aminoketones: Pro-oxidizing metabolic weapons
Bechara, E. J. H., Dutra, F., Cardoso, V. E. S., Sartori, A., Olympio, K. P. K., Penatti, C. A. A., Adhikari, A., & Assunção, N. A. (2007) · Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · doi:10.1016/j.cbpc.2006.07.004 · Cited by 57
“Another important biological consequence of Schiff's reaction is the formation of fluorescent adducts called Advanced Glycation End products (AGEs), or Maillard products, such as pentosidines (Monnier, 1989; Singh et al., 2001; Thornalley, 2002; Cameron et al., 2005; Monnier et al., 2005).”
Background
Metadata
- Authors
- MONNIER, V. M., SELL, D. R., & GENUTH, S.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2005-06
- Volume
- 1043
- Issue
- 1
- Pages
- 567-581
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2021375120
- Cited by
- 183
- References
- 0
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.